News

Research conducted at the Centenary Institute has given rise to a ground-breaking tool called 'Invasion-Block' that can identify drugs capable of halting the spread of cancer cells. The pioneering development could lead to better treatments for melanoma, the most dangerous form of skin cancer.

The discovery, led by the Centenary Institute and the University of Technology Sydney, could advance treatments for COPD, a lung condition that makes it difficult to breathe due to narrowed airways and damaged lung tissue. COPD is often caused by smoking or exposure to irritants. Lead study researcher, Dr Gang Liu at the Centenary UTS ...

The 2023 Centenary Celebration Symposium has taken place, bringing the entire Centenary Institute together, to reflect on achievements and successes of the past year while showcasing the ground-breaking research occurring at the Institute.

Centenary Institute researchers have been awarded an Australian Research Council (ARC) Discovery Project grant worth $709,714 to advance understanding of the intricate mechanisms underlying cellular ageing.

The Centenary UTS Centre for Inflammation has hosted the 17th Annual National Airways Meeting (NAMe) held at the Centenary Institute, 26-27 October 2023.

Professor Jennifer Gamble, a senior researcher in the Centenary Institute’s Centre for Healthy Ageing, has talked about her team’s research into Alzheimer’s disease in an interview on Radio 2GB’s Healthy Living program.

Dr Keshav Raj Paudel, a researcher at the Centenary UTS Centre for Inflammation, has been awarded a grant to investigate the health impacts associated with the inhalation and ingestion of microplastics.

A study by the Centenary Institute has revealed how a new mucosal (nasal delivered) vaccine can provide early protection against tuberculosis (TB) by drawing a particular type of immune cell into the lungs.

Researchers at the Centenary Institute have discovered a connection between the health of blood vessels and the development of Alzheimer’s disease. The findings suggest that early interventions aimed at improving blood vessel health offer an avenue for the advancement of new treatments for Alzheimer’s. A progressive brain disorder, Alzheimer’s disease causes memory loss, cognitive decline ...

The Centenary Institute and the University of Technology Sydney will lead pioneering research into age-related muscle loss, called sarcopenia, with a Dynamic Resilience Program contract from Wellcome Leap.

Researchers have discovered a new way to treat hepatocellular carcinoma (HCC), the most common type of liver cancer and the third leading cause of cancer death worldwide.

Dr Bobby Boumelhem, a dedicated researcher at the Centenary Institute, is on a mission to enhance the quality of life for individuals grappling with liver disease. Diseases such as hepatitis, liver cancer, non-alcoholic fatty liver disease and cirrhosis pose significant health challenges.